Dr. Mohd Cairul Iqbal Mohd Amin is a Professor of Pharmaceutics in the Faculty of Pharmacy, Universiti Kebangsaan Malaysia (UKM) in Kuala Lumpur, Malaysia. He is the youngest professor appointed in the faculty and the only expert in the area of pharmaceutics in UKM. He earned his BSc (Hons) in Pharmacy in 1996 and PhD in 2001 both from the University of Manchester, United Kingdom. He is currently the Head of Drug Delivery and Novel Targeting Research Group in UKM. He also serves as panel expert in nanocellulose for drug delivery for the National Nanotechnology Centre, Ministry of Science, Technology and Innovation, Malaysia. His current research interests encompass responsive-hydrogel biomaterials for oral protein and peptide delivery, cell delivery in tissue engineering and nano drug delivery systems in particular polymeric micellar conjugates for cancer research. Dr. Amin has authored more than 60 publications in high impact factor journals, a number of book chapters, has five patents issued/pending and has routinely consulted in the area of drug delivery and pharmaceutical technology. He has wide expertise in biomaterials, nanomedicine, polymer chemistry, micro- and nanotargeting delivery systems as well as oral and transdermal formulations and delivery systems. Dr. Khaled Greish is Professor of Molecular Medicine, and head of the Nano-research unit, at Princes Al-Jawhara Center, Arabian Gulf University, Kingdom of Bahrain. His previous appointments included Senior lecturer of Pharmacology at the University of Otago, New Zealand, and Assistant Professor of Pharmaceutical Chemistry at University of Utah (UT, USA). He has published > 70 peer reviewed papers, and 10 book chapters in the field of targeted anticancer drug delivery. Controlled Release Society (CRS) awarded him the CRS Postdoctoral Achievement Award in 2008 and in 2010; he was elected as member of the CRS College of Fellows. In recognition of his research, University of Otago awarded him “Early Career Awards for Distinction in Research” in 2014. His research focuses on Nanomedicine, tumor vascular biology, and anticancer drug discovery/development.

• SECTION 1: BIOMATERIALS - AN OVERVIEW 1. Overview of biomaterials in biomedical applicationsSECTION 2: BIOMATERIALS FOR DRUG DELIVERY1. Medium chain triglycerides and fractions in drug delivery systems2. Nanostructured lipid carrier phytoconstituents delivery3. Aloe vera in topical and transdermal drug delivery systems4. Biomaterials in inhalation and nasal drug delivery5. Lipid-based cubosomes for modified-release drug delivery6. Cationic nanoparticles for drug delivery targeting the brain7. Advances in biomaterials for targeted brain drug delivery8. Bacterial cellulose composites for drug and protein delivery9. Hydrogels for drug deliverySECTION 3: BIOMATERIALS FOR GENE, VACCINE AND THERAPEUTICS DELIVERY10. Marine-based biopolymers for gene delivery11. Biomaterials RNAi-, mRNA and DNA-based delivery and therapeutics12. Biomimetic nanoparticles as vaccine delivery platforms13. Bacterial cellulose composites for oral vaccine delivery14. Proteins and peptides for therapeutics15. Synthetic polymers for therapeuticsSECTION 4: BIOMATERIALS FOR WOUND AND TISSUE REGENERATION16. Biomaterials in tissue engineering – an introduction17. PLGA microparticles for wound healing18. Hydroxyapatite for bone tissue repair and regeneration19. Alginate biocomposite nanofibers in wound healing and tissue regeneration20. Nanocellulose biocomposites in wound healing applications21. Bacterial cellulose composites for cell delivery in wound healing22. Hydrogels for wound healingSECTION 5: BIOMATERIALS - SAFETY AND REGULATORY CONSIDERATIONS23. Zebrafish larvae models: Biomaterials safety for drug delivery24. Safety, biocompatibility, and preclinical considerations for biomaterials25. Regulatory considerations for biomaterials in medical applications